Our model predicts that a treatment that results in an average improvement in Hb of 1.1 g/dL (11 g/L) may be associated with a significantly lower rate of stroke, significantly increased IQ, and significantly more years of education completed [13]. The gene discussed is GSTM1; the disease is Stroke.